High blood pressure affects 1.3 billion people, is the #1 risk factor for death worldwide and the main cause of heart attacks, strokes, and heart failure. Nazata Bio is a digital therapeutics startup - it empowers patients to reduce their blood pressure via an app that acts as a specialist dietitian, an exercise coach and a behavioural scientist. Each patient's treatment is tailored based on a machine learning personalisation algorithm, so that every patient receives treatment optimised for their unique needs. Ultimately, this leads to the optimal reduction in blood pressure. For further details at https://www.nazatabio.com
| Website | https://www.nazatabio.com |
| Employees | 4 (2 on RocketReach) |
| Industry | Hospitals and Health Care |
| Keywords | Digital Therapeutics, Hypertension Management, Digital Health, Cardiovascular Health, Mobile Health, Heart Health, Telehealth Solutions, Remote Patient Monitoring, Patient Engagement, Stroke Prevention, Heart Failure Treatment, Therapeutic App, Virtual Care, Health Tech Startup, Personalized Medicine, Health Monitoring App, Mhealth, Clinical Decision Support, Wellness App |
| Competitors | ADM, Evonik, Corbion, Novozymes, Amyris, LanzaTech, Geno, Zymergen, Inc., Biomason, Aemetis +26 more (view full list) |
Looking for a particular Nazata Bio employee's phone or email?
Shane Neill is the Co-Founder and Chief Technology Officer of Nazata Bio.
2 people are employed at Nazata Bio.
Nazata Bio is based in Dublin, County Dublin.